Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04055376 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Apr 30, 2025 to Jan 15, 2027v11
  2. 5 versions Re-verified since Jun 29, 2020, no change to tracked fieldsv6-v10
  3. Primary and study completion dates: Apr 30, 2021 to Apr 30, 2025 Study description expanded, about 64 wordsv5 Show 1 more changeShow less
    • Study description expanded, about 64 words

    See this version in full on ClinicalTrials.gov ↗

  4. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 12 to confirmed 15 · Site details revisedv4 Show 2 more changesShow less
    • Enrollment target: estimated 12 to confirmed 15
    • Site details revised
  5. Study description expanded, about 24 wordsv3 See this version in full on ClinicalTrials.gov ↗
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this trial, the safety and effect of daily exposure to light and sound stimulation on people with mild Alzheimer's Disease (AD) will be studied. COVID-19 Amendment: Due to the ongoing suspension of all in-person humans subject research across MIT in response to the COVID-19 pandemic, all enrolled participants who have not completed their 6-month visit will have their visit postponed to 9 months with a follow up at 18 months. Subjects who have completed their 6-month visit will still be instructed to continue and return at Month 12 for an evaluation. OPTIONAL: If the subject would like to come in for an evaluation between Month 9 and 18, we will invite participants to come on Month 12 to complete cognitive testing and EEG.
Trial Details
NCT Number NCT04055376
Lead Sponsor Massachusetts Institute of Technology
Conditions Alzheimer Disease, Alzheimer Dementia
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov